Faculty mentor/PI email address
hurst@rowan.edu
Keywords
xenotransplantation, diabetes, ethics, islet cell
IRB or IACUC Protocol Number
G25061
Date of Presentation
5-6-2026 12:00 AM
Poster Abstract
Type 1 diabetes mellitus (T1D) necessitates life-sustaining insulin therapy or, in select cases, islet allotransplantation, which is limited by donor scarcity. Islet xenotransplantation (XTx; genetically modified pig-to-human transplant) is one potential alternative. Patient perceptions about islet XTx are largely unexplored. This study examined patient support for XTx when T1D patients learned that 25-50 pigs may be needed to treat one adult. Patient viewpoints toward islet XTx suggest animal ethics concerns may extend to the magnitude of animals required to treat a single patient. As clinical trials advance, addressing these values and risk tolerances is essential for developing informed consent frameworks that are sensitive to patient concerns.
Disciplines
Bioethics and Medical Ethics | Medicine and Health Sciences
Included in
Anticipating Animal Ethics Concerns in Islet Xenotransplantation
Type 1 diabetes mellitus (T1D) necessitates life-sustaining insulin therapy or, in select cases, islet allotransplantation, which is limited by donor scarcity. Islet xenotransplantation (XTx; genetically modified pig-to-human transplant) is one potential alternative. Patient perceptions about islet XTx are largely unexplored. This study examined patient support for XTx when T1D patients learned that 25-50 pigs may be needed to treat one adult. Patient viewpoints toward islet XTx suggest animal ethics concerns may extend to the magnitude of animals required to treat a single patient. As clinical trials advance, addressing these values and risk tolerances is essential for developing informed consent frameworks that are sensitive to patient concerns.